Invention Grant
- Patent Title: Recombinant expression of Chlamydia MOMP antigen
-
Application No.: US16894968Application Date: 2020-06-08
-
Publication No.: US11406695B2Publication Date: 2022-08-09
- Inventor: Lan Zhang , Zhiyun Wen , Craig T. Przysiecki , Ping Qiu
- Applicant: Merck Sharp & Dohme LLC
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme LLC
- Current Assignee: Merck Sharp & Dohme LLC
- Current Assignee Address: US NJ Rahway
- Agent Nichole M. Valeyko; Alysia Finnegan
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H19/00 ; C07H21/00 ; A61K39/118 ; A61K39/02 ; C07K14/295 ; A61P31/04 ; C12N15/70 ; A61K39/00

Abstract:
The present invention relates to methods for the recombinant expression of chlamydia major outer membrane protein (MOMP) comprising transforming a population of E. coli host cells with an expression vector comprising a nucleic acid molecule that encodes chlamydia MOMP and encodes a leader sequence for targeting the MOMP to the outer membrane of the cell, wherein the nucleic acid molecule is operatively linked to a promoter. The method of the invention allows expression of MOMP in the outer membrane of the cell, which leads to protein folding that is more like native MOMP relative to a MOMP protein that is expressed intracellularly. Also provided by the invention are uses of the recombinant MOMP in pharmaceutical compositions and methods for the treatment and/or prophylaxis of chlamydia infection and/or the effects thereof.
Public/Granted literature
- US20210093703A1 RECOMBINANT EXPRESSION OF CHLAMYDIA MOMP ANTIGEN Public/Granted day:2021-04-01
Information query